Canada Markets closed

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1100-0.1600 (-12.60%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.9000
52 Week Low 31.0700
50-Day Moving Average 31.6587
200-Day Moving Average 34.7851

Share Statistics

Avg Vol (3 month) 3746.34k
Avg Vol (10 day) 3690.34k
Shares Outstanding 534.6M
Implied Shares Outstanding 6N/A
Float 833.13M
% Held by Insiders 17.94%
% Held by Institutions 149.13%
Shares Short (Apr 28, 2022) 41.75M
Short Ratio (Apr 28, 2022) 41.58
Short % of Float (Apr 28, 2022) 45.43%
Short % of Shares Outstanding (Apr 28, 2022) 45.00%
Shares Short (prior month Mar 30, 2022) 41.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-597.32%

Management Effectiveness

Return on Assets (ttm)-23.34%
Return on Equity (ttm)-52.39%

Income Statement

Revenue (ttm)14.07M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)14.07M
EBITDA -81.26M
Net Income Avi to Common (ttm)-84.69M
Diluted EPS (ttm)-2.1490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)130.71M
Total Cash Per Share (mrq)3.74
Total Debt (mrq)45.6M
Total Debt/Equity (mrq)34.85
Current Ratio (mrq)11.79
Book Value Per Share (mrq)4.26

Cash Flow Statement

Operating Cash Flow (ttm)-76.06M
Levered Free Cash Flow (ttm)-48.09M